These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 7727820)
1. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Measuring quality of life. Avis NE; Czajkowski SM; Dew MA; Jette AM; McBride LR; Reedy JE; McKinlay SM; Watson JT ASAIO J; 1995; 41(1):32-41. PubMed ID: 7727820 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Study overview. LVAS Study Group. Left Ventricular Assist System. Pennington DG; Griffith BP; McKinlay SM; Oyer PE; Domanski MJ; Portner PM; Watson JT ASAIO J; 1995; 41(1):11-5. PubMed ID: 7727812 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Patient selection. LVAS Study Group. Left Ventricular Assist System. Pennington DG; Griffith BP; Swartz MT; McKinlay SM; Portner PM; Domanski MJ; Watson JT ASAIO J; 1995; 41(1):23-6. PubMed ID: 7727818 [No Abstract] [Full Text] [Related]
4. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Technical considerations. LVAS Study Group. Left Ventricular Assist System. Swartz MT; Borovetz HS; Miller PJ; Mitchell HE; Watson JT; Griffith BP; Pennington DG; Portner PM ASAIO J; 1995; 41(1):27-31. PubMed ID: 7727819 [No Abstract] [Full Text] [Related]
5. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Device explant protocol. Borovetz HS; Ramasamy N; Zerbe TR; Portner PM ASAIO J; 1995; 41(1):42-8. PubMed ID: 7727821 [TBL] [Abstract][Full Text] [Related]
6. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular assist devices as destination therapy: a new look at survival. Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Designing a randomized trial. McKinlay SM; Sleeper LA; Waclawiw MA; Follmann DA ASAIO J; 1995; 41(1):16-22. PubMed ID: 7727817 [No Abstract] [Full Text] [Related]
9. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation. Grady KL; Meyer PM; Dressler D; Mattea A; Chillcott S; Loo A; White-Williams C; Todd B; Ormaza S; Kaan A; Costanzo MR; Piccione W Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260 [TBL] [Abstract][Full Text] [Related]
11. Motivational interviewing to change quality of life for people with chronic heart failure: a randomised controlled trial. Brodie DA; Inoue A; Shaw DG Int J Nurs Stud; 2008 Apr; 45(4):489-500. PubMed ID: 17258218 [TBL] [Abstract][Full Text] [Related]
12. The integration of health quality of life in clinical research: experiences from cardiovascular clinical trials. Schron EB; Shumaker SA Prog Cardiovasc Nurs; 1992; 7(1):21-8. PubMed ID: 1518781 [TBL] [Abstract][Full Text] [Related]
13. Cardiac extracorporeal life support: state of the art in 2007. Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404 [TBL] [Abstract][Full Text] [Related]
14. How to anticipate the assessment of the public health benefit of new medicines? Massol J; Puech A; Boissel JP; Therapie; 2007; 62(5):427-35. PubMed ID: 18206104 [TBL] [Abstract][Full Text] [Related]
15. Predictors of quality of life at 1 month after implantation of a left ventricular assist device. Grady KL; Meyer P; Mattea A; Dressler D; Ormaza S; White-Williams C; Chillcott S; Kaan A; Todd B; Loo A; Klemme AL; Piccione W; Costanzo MR Am J Crit Care; 2002 Jul; 11(4):345-52. PubMed ID: 12102435 [TBL] [Abstract][Full Text] [Related]
16. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group. McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290 [TBL] [Abstract][Full Text] [Related]
17. HeartMate II left ventricular assist device: a new device for advanced heart failure. Delgado R; Bergheim M Expert Rev Med Devices; 2005 Sep; 2(5):529-32. PubMed ID: 16293063 [TBL] [Abstract][Full Text] [Related]
18. Quality of life assessment in heart failure interventions: a 10-year (1996-2005) review. Morgan K; McGee H; Shelley E Eur J Cardiovasc Prev Rehabil; 2007 Oct; 14(5):589-607. PubMed ID: 17925617 [TBL] [Abstract][Full Text] [Related]
19. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments]. Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P Encephale; 2003; 29(2):137-47. PubMed ID: 14567165 [TBL] [Abstract][Full Text] [Related]
20. Assessing responsiveness of generic and specific health related quality of life measures in heart failure. Eurich DT; Johnson JA; Reid KJ; Spertus JA Health Qual Life Outcomes; 2006 Nov; 4():89. PubMed ID: 17125512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]